Thursday, October 8, 2015: 2:00 PM-3:30 PM
Co-organized with the National Foundation for Infectious Diseases
At the conclusion of this session, participants will be able to:
- describe emerging technologies and diagnostic platforms for the diagnosis of common infections such as CNS infections, endocarditis, and endovascular infections.
- apply the optimal diagnostic tests for biothreat agents presenting in various clinical contexts.
- assess the benefits and limitations of advanced technologies to influence clinical decisions and improve patient outcomes.
Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians
Trainee, Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID
Cathy Petti, MD, Healthspring Global Inc
Maximum of 1.5 hours of AMA PRA Category 1 CreditTM
No CPE credit is offered for this session